Internet-Delivered ACT and Intermittent Theta Burst Stimulation for Subjective Sleep Quality in Depressed Adolescents: A Randomized Controlled Trial
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 160
- 试验地点
- 1
- 主要终点
- Change in subjective sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI)
研究概览
简要总结
This study evaluated whether combining an internet-delivered Acceptance and Commitment Therapy program with intermittent theta burst stimulation improves subjective sleep quality in adolescents with depressive disorders and sleep disturbances. Acceptance and Commitment Therapy is a psychological treatment that teaches skills for accepting difficult thoughts and feelings, reducing unhelpful struggle with them, and taking actions consistent with personal values. Intermittent theta burst stimulation is a brief, noninvasive form of brain stimulation delivered over the left dorsolateral prefrontal cortex.
A total of 152 adolescents aged 11 to 19 years were randomly assigned to one of four groups: combined internet-delivered Acceptance and Commitment Therapy plus intermittent theta burst stimulation, internet-delivered Acceptance and Commitment Therapy alone, intermittent theta burst stimulation alone, or a waitlist control group. Treatment was provided over 12 consecutive days. Participants completed assessments before treatment, immediately after treatment, and 30 days later.
The study was registered retrospectively after participant recruitment and data collection had begun. The primary outcome was subjective sleep quality, measured with the Pittsburgh Sleep Quality Index. Secondary outcomes were depressive symptom severity and psychological flexibility. The study also assessed treatment exposure and adverse events, including headache or scalp discomfort associated with brain stimulation.
详细描述
This was a four-arm, parallel-group, randomized controlled superiority trial conducted in the outpatient department of a psychiatric hospital in Anhui Mental Health Center. The study was retrospectively registered on the Open Science Framework in May 2024. The study protocol was approved by the institutional review board (Approval No.: CCNU-IRB-202306017b). Written informed consent was obtained from a parent or legal guardian, and written assent was obtained from each adolescent participant.
Participants were recruited by convenience sampling between August 2023 and January 2024. Eligible participants were 11 to 19 years old; had a primary DSM-5 depressive disorder confirmed by independent evaluations from two board-certified psychiatrists using semistructured clinical interviews; had a Hamilton Depression Rating Scale, 17-item version (HAMD-17) score of at least 8; and reported a concurrent subjective sleep disturbance, such as difficulty initiating sleep, frequent nighttime awakenings, or nonrestorative sleep. Participants were required either to be receiving stable antidepressant pharmacotherapy for at least 2 weeks or to be taking no antidepressant medication. Participants could not be receiving another systematic psychological or physical treatment and were required to be right-handed.
Participants were excluded for a history of epilepsy, a major neurological disorder, a contraindication to transcranial magnetic stimulation, acute suicide risk, a substance use disorder within the preceding year, severe somatic illness, or current use of targeted hypnotic or sedative medication.
Participants were randomly assigned in a 1:1:1:1 ratio using a computer-generated permuted-block randomization sequence. Allocation was managed by personnel independent of outcome assessment. Independent HAMD-17 raters were masked to treatment assignment. Participants and intervention-delivery personnel were not masked because the treatment formats and waitlist condition were distinguishable. Self-report outcome measures were completed by participants.
The internet-delivered Acceptance and Commitment Therapy program was provided through a custom-developed WeChat mini-program. The program included an introduction, six sequential treatment modules, and a concluding session. The content was delivered over 12 days and covered psychoeducation, acceptance, cognitive defusion, mindfulness, values clarification, and values-consistent action. The modules were unlocked on days 1, 3, 5, 7, 9, and 11, with approximately 15 minutes required for each component. The total planned exposure was approximately 120 minutes. All modules were completed on site during daily hospital visits. Online records and staff monitoring were used to document module completion and practice activities. A crisis hotline was embedded in the program.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 11 Years 至 19 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 11 to 19 years.
- •A primary depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), confirmed by independent evaluations conducted by two board-certified psychiatrists using semistructured clinical interviews. Any discrepancy was adjudicated by a senior psychiatrist.
- •Hamilton Depression Rating Scale, 17-item version (HAMD-17) score of at least
- •Current subjective sleep disturbance, including difficulty initiating sleep, frequent nighttime awakenings, or nonrestorative sleep, confirmed during the diagnostic interview.
- •Either no antidepressant medication or stable antidepressant pharmacotherapy for at least 2 weeks before enrollment.
- •No concurrent systematic psychological or physical treatment during the study.
- •Right-handedness.
- •Written informed consent from a parent or legal guardian and written assent from the adolescent participant.
排除标准
- •History of epilepsy, major neurological disorder, or any contraindication to transcranial magnetic stimulation, including relevant metal implants.
- •Acute suicide risk requiring immediate clinical intervention.
- •Substance use disorder within the previous year.
- •Severe somatic illness that could interfere with study participation or outcome assessment.
- •Current use of targeted hypnotic or sedative medication.
研究组 & 干预措施
Combined iACT and iTBS
Participants received intermittent theta burst stimulation once daily for 12 consecutive days and completed six sequential internet-delivered Acceptance and Commitment Therapy modules on days 1, 3, 5, 7, 9, and 11. On module days, iTBS was administered immediately before the iACT module.
干预措施: Internet-Delivered Acceptance and Commitment Therapy (Behavioral)
Combined iACT and iTBS
Participants received intermittent theta burst stimulation once daily for 12 consecutive days and completed six sequential internet-delivered Acceptance and Commitment Therapy modules on days 1, 3, 5, 7, 9, and 11. On module days, iTBS was administered immediately before the iACT module.
干预措施: Intermittent Theta Burst Stimulation (Device)
iACT Only
Participants completed six sequential internet-delivered Acceptance and Commitment Therapy modules over 12 days, with modules delivered on days 1, 3, 5, 7, 9, and 11.
干预措施: Internet-Delivered Acceptance and Commitment Therapy (Behavioral)
iTBS Only
Participants received intermittent theta burst stimulation over the left dorsolateral prefrontal cortex once daily for 12 consecutive days.
干预措施: Intermittent Theta Burst Stimulation (Device)
Waitlist Control
Participants received no targeted study intervention during the 42-day study period and completed assessments at the same time points as the active intervention groups. Participants were offered access to the iACT program after the final follow-up assessment.
结局指标
主要结局
Change in subjective sleep quality measured by the Pittsburgh Sleep Quality Index (PSQI)
时间窗: Baseline to immediately postintervention (day 12) and baseline to 30-day follow-up (day 42)
Subjective sleep quality will be assessed with the 19-item Pittsburgh Sleep Quality Index (PSQI). Total scores range from 0 to 21, with higher scores indicating poorer subjective sleep quality. The primary outcome is the change in PSQI total score from baseline to immediately after the 12-day intervention and from baseline to the 30-day follow-up. Negative change scores indicate improvement in subjective sleep quality.
次要结局
- Change in depressive symptom severity measured by the 17-item Hamilton Depression Rating Scale (HAMD-17)(Baseline to immediately postintervention (day 12) and baseline to 30-day follow-up (day 42))
- Change in psychological flexibility measured by the Multidimensional Psychological Flexibility Inventory-24 (MPFI-24)(Baseline to immediately postintervention (day 12) and baseline to 30-day follow-up (day 42))
研究者
Zhihong Ren
Professor
Central China Normal University
